Erectile dysfunction as a marker of silent cardiovascular disease in type-2 diabetic patients in Spain. The DIVA (DIabetes and VAscular disease) study;Disfunción eréctil como marcador de vasculopatía en la diabetes mellitus tipo 2 en España. Estudio DIVA

Medicina Clinica

Volumn 132, Issue 8, 2009, Pages 291-297

  González Juanatey, José Ramón ^a   Alegría Ezquerra, Eduardo ^b   Gomis Barberá, Ramón ^c   Salvador Taboada, María Jesús ^d   Grigorian Shamagian, Lilian ^a   Casasnovas Lenguas, José Antonio ^e   García Aranda, Víctor López ^f   Acosta Delgado, Domingo ^g   Salvador Rodríguez, Javier ^b   Hernández Mijares, Antonio ^h   Matalí Gilarranz, Arantxa ⁱ  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d INSTITUT UNIVERSITARI DEXEUS   (Spain)

^e HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^h HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

ⁱ Laboratorios Almirall S A Barcelona ^*  (Spain)

Author keywords

Cardiovascular disease; Diabetes mellitus; Erectile dysfunction; Registry

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ADULT; AGED; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE MARKER; ERECTILE DYSFUNCTION; FEMALE; GLYCEMIC CONTROL; HEALTH PRACTITIONER; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SPAIN; VASCULAR DISEASE;

EID: 61449109927     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2008.06.009     Document Type: Article

References (46)

1. Bosch X., Alfonso F., and Bermejo J. Diabetes y enfermedad cardiovascular. Una mirada hacia la nueva epidemia del siglo xxi. Rev Esp Cardiol 55 (2002) 525-527
2. Weiss J.S., and Sumpio B.E. Review of prevalence and outcome of vascular disease in patients with diabetes mellitus. Eur J Vasc Endovasc Surg 31 (2006) 143-150
3. Hobbs F.D.R. Reducing cardiovascular risk in diabetes: beyond glycemic and blood pressure control. Int J Cardiol 110 (2006) 137-145
4. Deedwania P.C., and Fonseca V.A. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm. Am J Med 118 (2005) 939-947
5. González-Juanatey J.R., Alegría E., García-Acuña J.M., González-Maqueda I., and Lozano J.V. Impacto de la diabetes en las enfermedades cardíacas en España. Estudio Cardiotens 1999. Med Clin (Barc) 116 (2001) 686-691
6. Palma J.L., Hernández-Madrid A., Bertomeu V., González-Juanatey R.J., López V., Calderón A., et al. La diabetes mellitus en la práctica de la cardiología en España. Encuesta del Grupo de Trabajo de Corazón y Diabetes sobre la importancia de la diabetes mellitus en relación con las enfermedades cardiovasculares. Rev Esp Cardiol 57 (2004) 661-666
7. Cockcroft J.R., Wilkinson I.B., Evans M., McEwan P., Peter J.R., Davies S., et al. Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus. Am J Hypertens 18 (2005) 1463-1467
8. Raggi P., Bellasi A., and Ratti C. Ischemia imaging and plaque imaging in diabetes: complementary tools to improve cardiovascular risk management. Diabetes Care 28 (2005) 2787-2794
9. Pfutzner A., and Forst T. High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technol Ther 8 (2006) 28-36
10. Jansson P.A. Endothelial dysfunction in insulin resistance and type 2 diabetes. J Intern Med 262 (2007) 173-183
11. Cheitlin M.D. Erectile dysfunction: the earliest sign of generalized vascular disease?. J Am Coll Cardiol 43 (2004) 185-186
12. Billups K.L., Bank A.J., Padma-Nathan H., Katz S., and Williams R. Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel. J Sex Med 2 (2005) 40-50
13. Vlachopoulos C., Rokkas K., Ioakeimidis N., and Stefanadis C. Inflammation, metabolic syndrome, erectile dysfuncytion, and coronary artery disease: common links. Eur Urol 52 (2007) 1590-1600
14. Ravipati G., McClung J.A., Aronow W.S., Peterson S.J., and Frishman W.H. Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease. Cardiol Rev 15 (2007) 76-86
15. Feldman H.A., Johannes C.B., Derby C.A., Kleinman K.P., Mohr B.A., Araujo A.B., et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 30 (2000) 328-338
16. Müller A., and Mulhall J.P. Cardiovascular disease, metabolic syndrome and erectile dysfunction. Curr Opin Urol 16 (2006) 435-443
17. Mulhall J., Teloken P., Brock G., and Kim E. Obesity, dyslipidemias and erectile dysfunction: a report of the sexual medicine society of North America. J Sex Med 3 (2006) 778-786
18. Eaton C.B., Liu Y.L., Mittleman M.A., Miner M., Glasser D.B., and Rimm E.B. A retrospective study of the relationship between biomarkers of atherosclerosis and erectile dysfunction in 988 men. Int J Impot Res 19 (2007) 218-225
19. Montorsi P., Ravagnani P.M., Galli S., Salonia A., Briganti A., Werba J.P., et al. Association between erectile dysfunction and coronary artery disease. Matching the right target with the right test in the right patient. Eur Urol 50 (2006) 721-731
20. Uslu N., Gorgulu S., Alper A.T., Eren M., Nurkalem Z., Yildirim A., et al. Erectile dysfunction as a generalized vascular dysfunction. J Am Soc Echocardiogr 19 (2006) 341-346
21. Foresta C, Palego P, Schipilliti M, Selice R, Ferlin A, Caretta N. Asymmetric development of peripheral atherosclerosis in patients with erectile dysfunction: an ultrasonographic study. Atherosclerosis. 2007 (en prensa).
22. Ganz P. Erectile dysfunction: pathophysiologic mechanisms pointing to underlying cardiovascular disease. Am J Cardiol 96 12B (2005) 8M-12M
23. Hodges L.D., Kirby M., Solanki J., O'Donnell J., and Brodie D.A. The temporal relationship between erectile dysfunction and cardiovascular disease. In J Clin Pract 61 (2007) 2019-2025
24. American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care 29 Supp 1 (2006) S4-S42
25. González-Juanatey J.R., Mazón P., Soria F., Barrios V., Rodríguez Padial L., and Bertomeu V. Actualización (2003) de las Guías de Práctica Clínica de la Sociedad Española de Cardiología en hipertensión arterial. Rev Esp Cardiol 56 (2003) 487-497
26. Cairols M., Castillo J., González-Juanatey J.R., Mostaza J.M., and Pomar J.L. Enfermedad arterial asintomática. Rev Clin Esp 3 (2003) 23-31
27. Mostaza J.M., Vicente I., Cairols M., Castillo J., González-Juanatey J.R., Pomar J.L., et al. Índice tobillo-brazo y riesgo vascular. Med Clin 121 (2003) 68-73
28. Rosenberg D.E., Jabbour S.A., and Goldstein B.J. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment. Diabetes Obes Metab 7 (2005) 642-663
29. Cordero A., Laclaustra M., Leon M., Grima A., Casasnovas J.A., Luengo E., et al. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) registry substudy. Am J Hypertens 19 (2006) 189-196
30. Grundy S.M., Brewer J.B., Cleeman J.I., Smith S.C., Lenfant C., and for the Conference Participants. Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation 109 (2004) 433-438
31. Rosen R.C., Riley A., Wagner G., Osterloh I.H., Kirkpatrick J., and Mishra A. The international index of erectile dysfunction (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49 (1997) 822-830
32. Prevost G., Phan T.M., Mounier-Vehier C., and Fontaine P. Control of cardiovascular risk factors in patients with type 2 diabetes and hypertension in a French national study (Phenomen). Diabetes Metab 31 (2005) 479-485
33. Pechere-Bertschi A., Greminger P., Hess L., Phillippe J., and Ferrari P. Swiss Hypertension and Risk Factor Program (SHARP): cardiovascular risk factors management in patients with type 2 diabetes in Switzerland. Blood Press 14 (2005) 337-344
34. Athyros V.G., Mikhailidis D.P., Papageorgiou A.A., Didangelos T.P., Ganotakis E.S., Symeonidis A.N., et al. Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study. Curr Med Res Opin 20 (2004) 1691-1701
35. Sánchez Merino J.M., García Alonso J., Gómez Cisneros S.C., Jiménez Rodríguez M., and Parra Montaner L. Prevalencia y factores de riesgo de la disfunción eréctil en la región del Bierzo. Arch Esp Urol 54 (2001) 229-239
36. Cuéllar de León A.J., Ruiz García V., Campos González J.C., Pérez Hoyos S., and Brotons Multó F. Prevalencia de la disfunción eréctil en pacientes con hipertensión. Med Clin (Barc) 119 (2002) 521-526
37. Sánchez de la Vega J., Amaya Gutiérrez J., Alonso Flores J.J., and García Pérez M. Disfunción eréctil en pacientes de menos de 40 años. Factores etiológicos y asociados. Arch Esp Urol 56 (2003) 161-164
38. Villamil Cajoto I., Díaz Peromingo J.A., Sánchez Leira J., García Suárez J., Saborido Forjan J., and Iglesias Gallego M. Disfunción eréctil: un problema poco valorado en Medicina Interna. Estudio de pacientes y medicación relacionada. An Med Interna 23 (2006) 115-118
39. Grover S.A., Lowensteyn I., Kaouache M., Marchand S., Coupal L., DeCarolis E., et al. The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease. Arch Intern Med 166 (2006) 213-219
40. Vela Navarrete R., García Cardoso J.V., Cabrera Pérez J., González Enguita C., Casado Pérez S., and Farre J. Impotencia y enfermedad cardiovascular: nueva perspectiva en el compromiso sanitario del urólogo. Arch Esp Urol 58 (2005) 43-53
41. Kostis B., Jackson G., Rosen R., Barrett-Connor E., Billups K., Burnett A.L., et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 96 (2005) 313-321
42. González-Juanatey J.R., Cea L., Bertomeu V., and Aznar J. Criterios electrocardiográficos de hipertrofia ventricular izquierda y perfil de riesgo cardiovascular en hipertensos. Estudio VIIDA. Rev Esp Cardiol 60 (2007) 148-156
43. Sáenz de Tejada I., Angulo J., Cellek S., González-Cadavid N., Heaton J., Pickard R., et al. Pathophysiology of erectile dysfunction. J Sex Med 2 (2005) 26-39
44. Papatsoris A.G., and Korantzopoulos P.G. Hypertension, antihypertensive therapy, and erectile dysfunction. Angiology 57 (2006) 47-52
45. Solomon H., Samarasinghe Y.P., Feher M.D., Man J., Rivas-Toro H., Lumb P.J., et al. Erectile dysfunction and statin treatment in high cardiovascular risk patients. Int J Clin Pract 60 (2006) 141-145
46. Chiurla E., D'Amico R., Ratti C., Granata A.R., Romagnoli R., and Modena M.G. Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J Am Coll Cardiol 46 (2005) 1503-1506